Vitaeris 320 Hyperbaric Chamber Review: Price, Features & Specs

The OxyHealth Vitaeris 320 is the most widely recognized portable hyperbaric chamber on the market, used in sports medicine clinics, integrative health centers, and high-end home setups. This review covers its real specifications, honest performance assessment, and how it compares to alternatives at the same and lower price points.

Vitaeris 320 Full Specifications

What Makes the Vitaeris 320 the Market Reference Point

The Vitaeris 320 earns its status as the market reference point through construction quality, not just brand recognition. The 44 oz double-sided polyurethane bladder with a rigid internal metal frame is a meaningfully more robust design than the fabric-only construction of lower-priced competitors.

The 0.01-micron inline air filtration is a specification you rarely see cited because most competitors do not offer it. For users with respiratory sensitivities or who are using the chamber in less-than-clean air environments, this is a practical feature.

The Vitaeris 320 is used by US Special Forces and the International Olympic Committee. These organizations conduct rigorous procurement evaluations. Their continued use of OxyHealth chambers is a meaningful institutional endorsement of product reliability.²

The 1.3 ATA Ceiling: What It Means Clinically

The Vitaeris 320 operates at a maximum of 1.3 ATA. This is the standard ceiling for all FDA-cleared soft chambers. Understanding what this means clinically is important for setting accurate expectations:

• At 1.3 ATA with ambient air, arterial oxygen is approximately 230 mmHg
• At clinical 2.4 ATA with 100% O2, arterial oxygen is approximately 1,824 mmHg, an 8x difference³
• Oxygen becomes bacteriostatic only above 1.5 ATA, the Vitaeris cannot reach this threshold³
• No UHMS-approved medical indication recommends treatment below 1.4 ATA⁴

Price vs Value: Is the Vitaeris 320 Worth $18,000–$23,000?

The Vitaeris 320 costs significantly more than alternatives. The honest comparison:

The Vitaeris 320 costs 2–3x what the Summit to Sea Grand Dive costs. Both deliver 1.3 ATA with FDA clearance. The Vitaeris wins on construction quality, 0.01-micron filtration, tamper-proof regulators, and the 5-year warranty. The Summit to Sea wins on value.

The OxyRevo Apex32 is a direct size competitor at $8,499 and reaches 1.5 ATA, a higher pressure than the Vitaeris. It lacks FDA clearance, but for buyers who prioritize pressure over regulatory status, this is a meaningful comparison.

The Vitaeris 320’s 5-year warranty on a $18,000–$23,000 investment is a meaningful financial protection. The Summit to Sea Grand Dive at $6,500–$8,500 delivers similar diameter and FDA clearance with a 2-year warranty. The premium you pay for Vitaeris is primarily for construction quality and warranty coverage.²

Who Should Buy the Vitaeris 320

The Vitaeris 320 is the right choice for:

• Buyers who want the most durable soft chamber available, the 44 oz bladder and rigid metal frame set it apart
• Clinic and wellness center operators, institutional build quality and 5-year warranty justify the price for commercial use
• Buyers who want US-made, FDA-cleared equipment and are not price-sensitive
• Users planning high-frequency use, daily sessions for years, where construction quality pays off over time

The Vitaeris 320 is not the right choice for:

• Budget-conscious buyers, the Summit to Sea or Newtowne deliver comparable function at $10,000–$18,000 less
• Users who need higher pressure, the 1.3 ATA ceiling applies here just as it does to all OxyHealth models

References

References

1. FDA 510(k) clearance. OxyHealth product documentation. accessdata.fda.gov. Accessed May 2026.
2. OxyHealth LLC. Vitaeris 320 specifications and institutional client list. oxyhealth.com. Accessed May 2026.
3. Burman F. Low-pressure fabric hyperbaric chambers. South African Medical Journal. 2019;109(4). PMID: 31084683
4. UHMS. Hyperbaric Oxygen Therapy Indications, 14th ed. uhms.org. Accessed May 2026.
5. Oxygen Health Systems. OxyHealth Vitaeris 320 comparison analysis. oxygenhealthsystems.com. Accessed May 2026.

Sources

• UHMS: Approved HBO Indications
• Mayo Clinic: Hyperbaric Oxygen Therapy
• FDA: Hyperbaric Oxygen Therapy Consumer Update

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website